IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biotech Medics Inc (BMCS)

Q3 2022 vs Q4 2022

Comparing institutional holders between quarters

Quarters

Q4 2022Q3 2022Q2 2022Q4 2021Q3 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Kovack Advisors, Inc.
UNCHANGED
Shares80,000 from 80,000
Change0 (0%)
Value$656 (+$654)
Filed 2023-02-22
Status
Kovack Advisors, Inc.
UNCHANGED80,00080,00000%$2$656+$6542023-02-22
Showing 1 of 1 institutions